Aethlon Medical Inc (AEMD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Aethlon Medical Inc (AEMD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile


  • Products Id :- GDPH16D
  • |
  • Pages: 37
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Aethlon Medical Inc (Aethlon Medical) is a developer of therapeutic technologies that address unmet needs in biodefense and global health. It develops immunotherapeutic technologies for the treatment of cancer and infectious diseases. The company's lead product, Hemopurifier, strengthens natural immunity in human immunodeficiency virus and hepatitis C virus infected patients. Its other pipeline products include HER2osome, for combating HER2+ breast cancer; and ELLSA exosome assay, which is an enzyme linked lectin specific assay to identify and quantify the presence of exosomes in HIV, HCV and tuberculosis. The company is also developing a medical device under the DARPA Sepsis program. Aethlon harnesses its ADAPT system to develop infrastructure of dialysis machines and CRRT systems in hospitals and clinics. Aethlon Medical is headquartered in San Diego, California, the US.

Aethlon Medical Inc (AEMD)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Aethlon Medical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Aethlon Medical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Aethlon Medical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Aethlon Medical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Aethlon Medical Inc, Medical Devices Deals, 2012 to YTD 2018 9

Aethlon Medical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Aethlon Medical Inc, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Exosome Sciences Enters into Research Agreement with Thomas Jefferson 11

Equity Offering 12

Aethlon Medical Raises USD6 Million in Public Offering of Units 12

Aethlon Medical Files Registration Statement for Public Offering of Shares for up to USD12.5 Million 13

Aethlon Medical Completes Fourth Tranche Of Private Placement Of Units For USD 1.8 Million 14

Debt Offering 15

Aethlon Medical Completes Private Placement Of 5% Original Issue Discount Unsecured Convertible Debentures For USD 1.8 Million 15

Aethlon Medical Inc-Key Competitors 16

Aethlon Medical Inc-Key Employees 17

Aethlon Medical Inc-Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Recent Developments 19

Financial Announcements 19

Aug 08, 2018: Aethlon Medical announces first quarter fiscal year 2019 results 19

Jun 08, 2018: Aethlon Medical Reports Fiscal 2018 Financial Results 20

Feb 01, 2018: Aethlon Medical Announces Fiscal 2018 Third Quarter Results 22

Nov 02, 2017: Aethlon Medical Announces Fiscal 2018 Second Quarter Results 24

Aug 10, 2017: Aethlon Medical Announces Fiscal 2018 First Quarter Results 25

Jun 28, 2017: Aethlon Medical Announces Fiscal 2017 Results 27

Feb 10, 2017: Aethlon Medical Announces Fiscal 2017 Third Quarter Results 29

Corporate Communications 31

Jun 25, 2018: Aethlon Medical Names Guy Cipriani As Board Director 31

Jan 10, 2018: Sabrina Martucci Johnson Joins Aethlon Medical's Board of Directors 32

Nov 09, 2017: Dr. Charles J. Fisher, Jr. Joins Aethlon Medical's Board of Directors 33

Government and Public Interest 34

Apr 24, 2017: Aethlon Medical Releases Shareholder Update 34

Other Significant Developments 35

Jan 11, 2017: Aethlon Medical Provides Clinical Study Update and a Review of 2016 Accomplishments 35

Appendix 37

Methodology 37

About GlobalData 37

Contact Us 37

Disclaimer 37

List of Figures

Aethlon Medical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Aethlon Medical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Aethlon Medical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Aethlon Medical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Aethlon Medical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Aethlon Medical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Aethlon Medical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Aethlon Medical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Aethlon Medical Inc, Medical Devices Deals, 2012 to YTD 2018 9

List of Tables

Aethlon Medical Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2

Aethlon Medical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Aethlon Medical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Aethlon Medical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Aethlon Medical Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Aethlon Medical Inc, Medical Devices Deals, 2012 to YTD 2018 9

Aethlon Medical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Exosome Sciences Enters into Research Agreement with Thomas Jefferson 11

Aethlon Medical Raises USD6 Million in Public Offering of Units 12

Aethlon Medical Files Registration Statement for Public Offering of Shares for up to USD12.5 Million 13

Aethlon Medical Completes Fourth Tranche Of Private Placement Of Units For USD 1.8 Million 14

Aethlon Medical Completes Private Placement Of 5% Original Issue Discount Unsecured Convertible Debentures For USD 1.8 Million 15

Aethlon Medical Inc, Key Competitors 16

Aethlon Medical Inc, Key Employees 17

Aethlon Medical Inc, Subsidiaries 18

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Aethlon Medical Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 17500
Site License
USD 500 INR 35000
Corporate User License
USD 750 INR 52500

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com